The Jesse Chappus Show 698: Is LDL Really Causing Heart Disease? | Dr. Aseem Malhotra
8 snips
Mar 31, 2026 
Dr. Aseem Malhotra, a cardiologist and public health advocate known for challenging cholesterol orthodoxy. He argues insulin resistance, inflammation, and clotting drive coronary disease, critiques widespread statin use, and outlines lifestyle strategies—low‑carb Mediterranean diet, walking, resistance training, stress reduction—to reverse plaque and improve metabolic markers.
AI Snips
Chapters
Books
Transcript
Episode notes
Statin Benefits May Come From Anti-Inflammation Not LDL
- Statins likely confer benefit primarily via anti-inflammatory and anti-clotting effects, not LDL lowering per se.
- Malhotra's systematic review found no clear relationship between LDL reduction magnitude and event prevention across statin and other cholesterol-lowering trials.
Statin Benefits Look Bigger When Framed Relatively
- Statin trial results are often presented as relative risk reduction, which exaggerates benefit; absolute benefit can be as small as 1 in 100 over five years in primary prevention.
- Malhotra urges clinicians to use numbers needed to treat and honest informed consent when discussing statins.
Collateral Vessels Can Compensate For Blocked Arteries
- Collateral vessel growth can protect patients with slowly developing blockages, explaining why some people tolerate major occlusions without heart attacks.
- Malhotra observed angiograms where alternative vessels compensated for completely blocked arteries.
